Manhattan Scientifics, Inc. (MHTX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Manhattan Scientifics Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.11M |
| March 31, 2024 | -0.157M |
| December 31, 2023 | -0.19M |
| September 30, 2023 | -0.263M |
| June 30, 2023 | -0.314M |
| March 31, 2023 | -0.313M |
| December 31, 2022 | -0.349M |
| September 30, 2022 | -0.386M |
| June 30, 2022 | -0.397M |
| March 31, 2022 | -0.436M |
| December 31, 2021 | -0.421M |
| September 30, 2021 | -0.418M |
| June 30, 2021 | -0.404M |
| March 31, 2021 | -0.384M |
| December 31, 2020 | -0.388M |
| September 30, 2020 | -0.34M |
| June 30, 2020 | -0.343M |
| March 31, 2020 | -0.317M |
| December 31, 2019 | -0.316M |
| September 30, 2019 | -0.398M |
| June 30, 2019 | -0.698M |
| March 31, 2019 | -0.577M |
| December 31, 2018 | -0.682M |
| September 30, 2018 | 0.258M |
| June 30, 2018 | 0.507M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.142M |
| December 31, 2017 | -0.791M |
| September 30, 2017 | -2.513M |
| June 30, 2017 | -3.133M |
| March 31, 2017 | -4.257M |
| December 31, 2016 | -4.559M |
| September 30, 2016 | -4.728M |
| June 30, 2016 | -5.376M |
| March 31, 2016 | -5.129M |
| December 31, 2015 | 3.415M |
| September 30, 2015 | 3.713M |
| June 30, 2015 | 4.197M |
| March 31, 2015 | 5.272M |
| December 31, 2014 | -2.535M |
| September 30, 2014 | -2.232M |
| June 30, 2014 | -1.788M |
| March 31, 2014 | -2.284M |
| December 31, 2013 | -0.964M |
| September 30, 2013 | -0.833M |
| June 30, 2013 | -0.73M |
| March 31, 2013 | -0.618M |
| December 31, 2012 | -1.078M |
| September 30, 2012 | -1.104M |
| June 30, 2012 | -1.192M |
| March 31, 2012 | -1.254M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Exicure, Inc. | -6.704M |
| Century Therapeutics, Inc. | -86.74M |
| Absci Corp. | -108.08M |
| Celularity, Inc. | -13.25M |